Please try another search
© Reuters.
By Gina Lee
Investing.com – Gold was down on Thursday morning in Asia, with investor sentiment boosted by positive results from yet another potential COVID-19 vaccine.
U.S. pharmaceutical company Pfizer (NYSE:PFE) announced the results from the early stage human trial for BNT162b1, its mRNA candidate jointly developed with German biotech firm BioNTech (NASDAQ:BNTX), on Wednesday. The results showed production of neutralizing antibodies in all the patients who were inoculated after 28 days.
Pfizer also has three other mRNA candidates under development.
Gold futures slid 0.16% to $1,777.05 by 12:15 AM ET (5:15 AM GMT), as investors retreated from the safe-haven asset as their appetite for riskier assets increased. Stocks, which usually move in the opposite direction to gold, were up on Thursday.
But the yellow metal could yet gain back its shine. The ever-increasing numbers of COVID-19 cases prompted the World Health Organization to warn on Wednesday that re-instatement of lockdown measures could be required for some countries. California heeded the call on the same day as the state reimplemented some lockdown measures including bar closures and bans on indoor restaurant dining.
Meanwhile, the number of COVID-19 cases has surpassed the 10.6 million mark, according to data from Johns Hopkins University.
By Isabel Kua SINGAPORE (Reuters) -Oil prices steadied on Tuesday after rising in the previous session on concerns that further U.S. interest rate hikes this week to tame...
SYDNEY (Reuters) - Robust commodity prices have helped narrow Australia's budget deficit for the last fiscal year by about A$50 billion ($34 billion), Treasurer Jim Chalmers said...
By Ross Kerber (Reuters) - Top farming and food firms could lose up to a quarter of their value by 2030 if they do not adapt to new government policies and consumer behavior tied...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for reviewWe've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using Investing.com, please allow this domain on your ad blocker.
Allow this domain
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.